Outset Medical, Inc. (OM)
- Previous Close
2.5500 - Open
2.4700 - Bid 2.3600 x 600
- Ask 2.4100 x 400
- Day's Range
2.2950 - 2.4720 - 52 Week Range
1.9200 - 24.1300 - Volume
806,537 - Avg. Volume
965,172 - Market Cap (intraday)
123.051M - Beta (5Y Monthly) 1.98
- PE Ratio (TTM)
-- - EPS (TTM)
-3.4800 - Earnings Date May 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.79
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
www.outsetmedical.comRecent News: OM
Performance Overview: OM
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OM
Valuation Measures
Market Cap
131.84M
Enterprise Value
64.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.97
Price/Book (mrq)
1.07
Enterprise Value/Revenue
0.50
Enterprise Value/EBITDA
-0.42
Financial Highlights
Profitability and Income Statement
Profit Margin
-132.54%
Return on Assets (ttm)
-29.73%
Return on Equity (ttm)
-93.69%
Revenue (ttm)
130.38M
Net Income Avi to Common (ttm)
-172.8M
Diluted EPS (ttm)
-3.4800
Balance Sheet and Cash Flow
Total Cash (mrq)
203.32M
Total Debt/Equity (mrq)
110.83%
Levered Free Cash Flow (ttm)
-71.68M